As the embryonic stem cell research oversight (ESCRO) manager for an academic institution, I routinely monitor local, national, and [...] Read more
Collaboration between IRBs and IBCs offers immediate and long-term benefits—especially when it comes to reviewing human gene transfer research projects. This effort not only ensures that regulatory requirements are met, but that risks and potential benefits are clearly communicated to research participants.
So, where might you begin bridging the gap? You could start by attending Institutional Biosafety Committees: Promoting Optimal Practice Now and in the Future. Hosted by the National Institutes of Health Office of Biotechnology Activities (NIH OBA) and the Eagleson Institute on June 24-26, this meeting aims to help biosafety professionals expand their knowledge of research [...] Read more